Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Respiratory Tract Diseases | 0.800 | 1.000 | 20 | 2010 | 2015 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Respiratory Tract Diseases | 0.800 | 1.000 | 19 | 2010 | 2015 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms | 0.900 | 0.889 | 18 | 2009 | 2020 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 1.000 | 18 | 2010 | 2015 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.750 | 1.000 | 11 | 2011 | 2019 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms | 0.880 | 1.000 | 11 | 2009 | 2016 | |||||||
|
0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 |
|
Neoplasms | 0.100 | 0.900 | 10 | 2010 | 2018 | ||||||
|
0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 |
|
Neoplasms | 0.100 | 0.900 | 10 | 2010 | 2018 | ||||||
|
0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.090 | 1.000 | 9 | 2009 | 2018 | ||||||
|
0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.090 | 1.000 | 9 | 2009 | 2018 | ||||||
|
0.600 | 0.600 | 5 | 1293971 | synonymous variant | C/T | snv | 0.29 | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.090 | 1.000 | 9 | 2009 | 2018 | ||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.750 | 1.000 | 8 | 2011 | 2019 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms | 0.080 | 1.000 | 8 | 2009 | 2016 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.080 | 1.000 | 8 | 2014 | 2019 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms | 0.070 | 1.000 | 7 | 2010 | 2017 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms | 0.070 | 1.000 | 7 | 2012 | 2018 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms | 0.070 | 1.000 | 7 | 2012 | 2018 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Respiratory Tract Diseases | 0.060 | 1.000 | 6 | 2009 | 2016 | |||||||
|
0.667 | 0.560 | 5 | 1288432 | intron variant | T/A;C | snv |
|
Neoplasms | 0.840 | 1.000 | 6 | 2009 | 2017 | ||||||||
|
0.882 | 0.120 | 5 | 1294282 | missense variant | C/T | snv | 3.2E-04 | 1.8E-04 |
|
0.800 | 1.000 | 5 | 2005 | 2012 | |||||||
|
0.882 | 0.120 | 5 | 1279341 | missense variant | C/T | snv | 7.0E-06 |
|
0.800 | 1.000 | 5 | 2005 | 2012 | ||||||||
|
0.925 | 0.120 | 5 | 1272252 | missense variant | T/C | snv |
|
0.800 | 1.000 | 5 | 2005 | 2012 | |||||||||
|
0.851 | 0.120 | 5 | 1254395 | missense variant | C/T | snv | 5.2E-05 | 9.1E-05 |
|
0.700 | 1.000 | 5 | 2005 | 2012 | |||||||
|
0.882 | 0.160 | 5 | 1266524 | missense variant | C/T | snv | 8.2E-06 | 7.0E-06 |
|
0.800 | 1.000 | 5 | 2005 | 2012 | |||||||
|
0.925 | 0.040 | 5 | 1272196 | missense variant | C/T | snv | 9.0E-05 | 1.5E-04 |
|
0.700 | 1.000 | 5 | 2005 | 2012 |